8-K: Health Catalyst Exceeds Q1 Expectations, Reaffirms Full-Year Guidance

Health Catalyst reported strong first-quarter 2024 financial results, surpassing the midpoint of its guidance for both revenue and Adjusted EBITDA, and reiterated its full-year outlook.

Summary

• Health Catalyst announced its financial results for the first quarter of 2024, ending March 31, 2024.
• The company's total revenue for the quarter was $74.7 million, a 1% increase compared to $73.9 million in the same quarter of the previous year.
• Adjusted EBITDA for the quarter was $3.4 million, a decrease of 19% compared to $4.2 million in the first quarter of 2023.
• The company reported a net loss of $20.6 million, which is an improvement from the $33.2 million loss in the same quarter of the previous year.
• Health Catalyst is reiterating its full-year 2024 revenue guidance of $304 million to $312 million and Adjusted EBITDA guidance of $24 million to $26 million.
• The company also reaffirmed its bookings metrics, including a dollar-based retention rate between 104% and 110% and mid-teens net new DOS Subscription client additions.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the company exceeding guidance on revenue and Adjusted EBITDA, and improving net loss. However, the decrease in Adjusted EBITDA year-over-year and the continued net loss temper the overall sentiment.

Positives

• The company's revenue of $74.7 million exceeded the midpoint of its guidance.
• Adjusted EBITDA of $3.4 million also exceeded the midpoint of its guidance.
• The net loss of $20.6 million is a significant improvement compared to the previous year's loss of $33.2 million.
• The company is reiterating its full-year revenue and Adjusted EBITDA guidance.
• Health Catalyst is seeing pipeline development and growth across new and existing clients.
• The company held a successful Healthcare Analytics Summit with nearly 1,000 attendees.
• Health Catalyst announced an expansion with Saudi German Health.

Negatives

• Adjusted EBITDA decreased by 19% year-over-year, from $4.2 million to $3.4 million.
• The company still reported a net loss of $20.6 million for the quarter.

Risks

• Changes in laws and regulations could impact the business model.
• Market or industry conditions, regulatory environment, and receptivity to technology and services could change.
• The company could face negative impacts from litigation or security incidents.
• The loss of key clients or partners could affect results.
• The challenging macroeconomic environment, including high inflation and interest rates, could impact the business.
• The company's ability to recruit and retain qualified team members could be affected.

Future Outlook

Health Catalyst is reiterating its full-year 2024 revenue guidance of $304 million to $312 million and Adjusted EBITDA guidance of $24 million to $26 million. The company is also guiding to Q2 2024 revenue of $73.5 million to $76.5 million and Adjusted EBITDA of $5.0 million to $7.0 million.

Management Comments

• Dan Burton, CEO of Health Catalyst, stated that he was pleased by the strong financial results, including total revenue of $74.7 million and Adjusted EBITDA of $3.4 million, which beat the mid-point of the quarterly guidance on each metric.
• The CEO also mentioned that the financial performance demonstrates the company's ability to continue to scale its business as it drives toward its long-term profitability goals.
• Management anticipates that improving health system operating margins will be a bookings tailwind in 2024 and beyond.

Industry Context

The healthcare industry is increasingly focused on data-driven decision-making, which positions Health Catalyst well with its data and analytics technology and services. The company's focus on improving healthcare outcomes through data aligns with broader industry trends towards value-based care and operational efficiency. The company is also seeing improved health system operating margins which is expected to be a tailwind for bookings.

Comparison to Industry Standards

• Health Catalyst's revenue growth of 1% year-over-year is modest compared to some high-growth SaaS companies in the healthcare analytics space, which may see growth rates in the double digits.
• However, the company's focus on Adjusted EBITDA and profitability is a positive sign, as many companies in the sector are still focused on growth at the expense of profitability.
• Companies like Cerner (now Oracle Health) and Epic Systems are major competitors in the healthcare IT space, but Health Catalyst differentiates itself with its focus on data analytics and its cloud-based platform.
• The company's dollar-based retention rate of 104% to 110% is a good indicator of customer satisfaction and recurring revenue, which is a key metric for SaaS businesses.
• The company's Adjusted EBITDA of $3.4 million is a positive sign of improving profitability, but it is still relatively low compared to more established companies in the sector.

Stakeholder Impact

• Shareholders will likely react positively to the better-than-expected financial results and reaffirmed guidance.
• Employees may be encouraged by the company's progress and focus on profitability.
• Customers may benefit from the company's continued investment in its platform and services.
• Suppliers and creditors may view the company's financial stability as a positive sign.

Next Steps

• The company will host a conference call to review the results on May 9, 2024.
• The company will continue to focus on scaling its business and driving towards long-term profitability goals.
• The company will continue to develop and grow its pipeline across new and existing clients.

Key Dates

Keywords

Health Catalyst, Healthcare Analytics, Data Analytics, Financial Results, Adjusted EBITDA, Revenue, Net Loss, Guidance, Bookings, DOS Subscription, Healthcare Technology